We believe that DM mortality rates in cats should be reviewed, based on the licensing of SGLT‐2 inhibitors in the UK, simplifying diabetic management and minimizing effects on owners' and their cats' QoL. The gene discussed is SLC5A2; the disease is diabetes mellitus.